[Evaluation of the results of treatment with medroxyprogesterone acetate (MPA) of patients with advanced breast cancer].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D009367:Neoplasm Staging
D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Ocena wyników leczenia octanem medroxyprogesteronu (medroxyprogesterone acetate MPA) chorych kobiet na zaawansowanego raka sutka.